Allergan
This article was originally published in The Tan Sheet
Executive Summary
"Positive performance in the U.S. contact lens care market" is not enough to prevent an 8.3% drop in worldwide contact lens care sales to $72.9 mil. for the first quarter, the company announces April 27. Global Consept F sales dropped 15.4% to $8.8 mil., while Complete sales increased 44.3%, reflecting "transition from multibottle oxidative systems to non-oxidative, one-bottle systems," Allergan says. Contact lens sales declined 7% to $5.6 mil. at constant currency levels. A 20.8% increase in consolidated sales to $376.2 mil. for the quarter led to a 24.3% improvement in net earnings, which reached $43.5 mil compared to the year-ago period
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
People In Brief
Perrigo promotes in pricing, planning
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: